Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 May;55(5):934-8.
doi: 10.1016/s0015-0282(16)54302-7.

Programming in vitro fertilization for a 5- or 3-day week

Affiliations
Free article

Programming in vitro fertilization for a 5- or 3-day week

E S Dimitry et al. Fertil Steril. 1991 May.
Free article

Abstract

Objective: To schedule oocyte retrievals on either 5 or 3 days per week in in vitro fertilization (IVF) cycles.

Design: Human chorionic gonadotropin (hCG) administration was delayed by at least 24 hours in patients undergoing superovulation to avoid egg collections on weekends (group 1). Encouraged by the results, a further prospective study in which oocyte retrievals were programmed for only 3 days a week was undertaken (group 2).

Setting: Hammersmith Hospital, a tertiary referral unit.

Patients: All patients undergoing IVF treatment were included.

Main outcome measures: To schedule oocyte retrievals on either 5 or 3 days per week.

Results: Only 4.0% of egg collections (12/303) occurred on weekends compared with 12.6% (22/175) before delaying hCG. In group 2 (n = 215), only four egg collections (2.1%) had to be performed out of schedule. Delaying administration of hCG had no detrimental effects.

Conclusions: Delayed administration of hCG allows scheduling oocyte retrievals on either 5 or 3 days per week, leading to a substantial decrease in out-of-hours oocyte retrievals, reducing cycle costs, and facilitating efficiency. The method is applicable to assisted reproduction specialized units as well as district general hospitals that use gonadotropin-releasing hormone analogs in their superovulation regimens before IVF, gamete intrafallopian transfer, or intrauterine insemination.

PubMed Disclaimer

Similar articles

Cited by

Substances

LinkOut - more resources